ICDDR Dhaka Bangladesh Completes Successful Ivermectin Clinical Trial

ICDDR Dhaka Bangladesh Completes Successful Ivermectin Clinical Trial

The International Center for Diarrheal Disease Research (ICDDR) in Dhaka, Bangladesh, reported that a clinical trial investigating ivermectin has proven significantly effective in treating COVID-19 patients in this country. With findings recently disclosed by the ICDDR at a Dhaka seminar, the study revealed that COVID-19 patients who voluntarily participated in a study involving ivermectin for a five day period evidences a 77%  greater chance of achieving viral clearance after 14 days as compared to those patients that received a combination of ivermectin and doxycycline (61%) and those on the standard placebo (39%). 18% of those patients on ivermectin started to see viral clearance by the third day as compared to only 3% viral clearance for those participants taking ivermectin plus doxycycline and a placebo. By the seventh day, those patients on ivermectin demonstrated 50% viral clearance while those on both ivermectin and doxycycline equaled 30% and patients on placebo achieved viral clearance on the seventh day at only 13%.

Ivermectin in Bangladesh

This nation of 165 million people has a total of 6,874 confirmed coronavirus deaths with 36 fatalities recorded in the past 2...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee